Advertisement
AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


AJPH First Look, published online ahead of print May 21, 2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
AJPH.2008.157602v1
99/S2/S378    most recent
Right arrow Submit a response
Right arrow purchase articles
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Get other permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Leon, K.
Right arrow Articles by Rust, G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leon, K.
Right arrow Articles by Rust, G.
©
American Journal of Public Health, 10.2105/AJPH.2008.157602


Research and Practice

Disparities in Influenza Treatment Among Disabled Medicaid Patients in Georgia

Kyla Leon 1, Marian C. McDonald 2*, Barbara Moore 1, George Rust 1

1 Morehouse School of Medicine
2 Centers for Disease Control and Prevention

* To whom correspondence should be addressed. E-mail: mmcdonald{at}cdc.gov.


   Abstract

Objectives. We explored possible disparities in seasonal influenza treatment in Georgia’s disabled Medicaid population. We sought to determine whether racial/ethnic, geographic, or gender disparities existed in antiviral drugs usage in the treatment of influenza.

Methods. Medicaid claims were analyzed from 69556 clients with disabilities enrolled in a Georgia Medicaid disease management program.

Results. There were 519 patients who met inclusion criteria (i.e., adults aged 18–64 years with an influenza diagnosis on a 2006 or 2007 Medicaid claim). Roughly one third (36.2%) of patients were classified as African American, 44.5% as White, and 19.3% as "other" Most patients had 2 or more comorbid chronic diseases. Antivirals were used in only 14.5% of patients diagnosed with influenza. Treatment rates were nearly 3 times higher for White patients (19.5%) than for African American patients (6.9%).

Conclusions. Our analysis suggests limited use of antiviral treatment of influenza overall, as well as significant racial disparities in treatment. Additional studies are needed to further explore this finding and its implications for care of racial/ethnic minority populations during seasonal influenza and for effective pandemic influenza planning for racial/ethnic minority populations.

Key Words: Disability, Insurance, Health Service Delivery, Infections, Race/Ethnicity, Rural Health




This article has been cited by other articles:


Home page
AJPHHome page
S. S. Hutchins, B. I. Truman, T. L. Merlin, and S. C. Redd
Protecting Vulnerable Populations From Pandemic Influenza in the United States: A Strategic Imperative
Am J Public Health, October 1, 2009; 99(S2): S243 - S248.
[Abstract] [Full Text] [PDF]


Home page
AJPHHome page
G. Rust, M. Melbourne, B. I. Truman, E. Daniels, Y. Fry-Johnson, and T. Curtin
Role of the Primary Care Safety Net in Pandemic Influenza
Am J Public Health, October 1, 2009; 99(S2): S316 - S323.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2009 by the American Public Health Association